Evicenter
MarkdownMedical informationP&T meetings
Lonimecgene renparvovec (TSHA-102)

Rett syndrome

Launch
Not announced
Last updated
199 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Bone health management

6 evidence topics · 4 sources

Bone health guideline: non-pharmacological and pharmacological statements with panel agreement
InterventionStatementPanel agreement, n/N (%)
Physical activity“Increase physical activity in order to increase muscle strength and bone density”View highlighted excerpt for this quote“34/34 (100)”View highlighted excerpt for this quote
Standing frame“Use a standing frame for at least 30 minutes a day”View highlighted excerpt for this quote“28/33 (84.8)”View highlighted excerpt for this quote
Targeted exercise“Where mobility is limited, targeted exercise such as body weight supported treadmill or assisted walking is recommended”View highlighted excerpt for this quote“31/32 (96.9)”View highlighted excerpt for this quote
Dietary calcium“If calcium intake is low, increase dietary intake of calcium rich or calcium fortified foods”View highlighted excerpt for this quote“31/32 (96.9)”View highlighted excerpt for this quote
Bisphosphonate indication“Bisphosphonates should be used if the International Society for Clinical Densitometry criteria for osteoporosis in children and adolescents are fulfilled”View highlighted excerpt for this quote“17/23 (73.9)”View highlighted excerpt for this quote
Bisphosphonate reassessment“Reassess bone mineral content and areal bone mineral density one year after Bisphosphonate therapy to decide on further therapy”View highlighted excerpt for this quote“24/26 (92.3)”View highlighted excerpt for this quote
Hormonal contraception“If hormonal intervention for regulation of the menstrual cycle is needed, use of Depot medroxyprogesterone acetate (DMPA) should be avoided”View highlighted excerpt for this quote“21/21 (100)”View highlighted excerpt for this quote